ACETYLCYSTEINE
- Product NDC
- 72611-860
- 11-digit product format
- 726110860
- Labeler code
- 72611
- Product ID
- 72611-860_c32fe773-7b1e-a499-c4ca-c6cee49da0c5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ACETYLCYSTEINE
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Almaject, Inc.
- Application
- ANDA215620
- Marketing category
- ANDA
- Marketing start
- 2022-10-17
- Marketing end
- 0000-00-00
- Substance
- ACETYLCYSTEINE
- Active strength
- 200 mg/mL
- Pharmacologic classes
- Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72611-860 | ACETYLCYSTEINE INJECTION [ALMAJECT, INC.] | 4 | Legacy NDC | 20250117_0298bda7-0edf-99c7-8266-ab45bb5c6e16.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72611-860-04 | 72611086004 | 4 VIAL, SINGLE-DOSE in 1 CARTON (72611-860-04) > 30 mL in 1 VIAL, SINGLE-DOSE (72611-860-01) | 2022-10-24 | 0000-00-00 | No | No | Current |